<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="c57982f2-c7da-488a-7ea9-b9609439ac68"><labelDrug name="COREG"><Normalization><mmtx cui="C0719509" preferredWord="Coreg" semType="phsu, orch"/></Normalization></labelDrug><generic name="carvedilol"/><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.1" text="COREG (carvedilol) tablet, film coated" type="negative"><entity charOffset="0:5" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.1.e.0" text="coreg" type="Biomedical_Entity"><Normalization><mmtx cui="C0719509" phraseText="COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><entity charOffset="7:17" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.1.e.1" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="(carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.1.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.1.e.1"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2" text="COREG is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization." type="negative"><entity charOffset="150:164" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors," preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="139:148" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="usually in addition to diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="170:179" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.2" text="digitalis" type="Biomedical_Entity"><Normalization><mmtx cui="C0304520" phraseText="digitalis," preferredWord="Digitalis preparation" semType="phsu, carb"/><RxNorm RxCui="91235"/></Normalization></entity><entity charOffset="0:5" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.3" text="coreg" type="Biomedical_Entity"><Normalization><mmtx cui="C0719509" phraseText="COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.0"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.2"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.3" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.0"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.2"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.3" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.1"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.3" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.2.e.2"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.39" text="If such symptoms occur, diuretics should be increased and the carvedilol dose should not be advanced until clinical stability resumes [see Dosage and Administration (2)]. " type="negative"><entity charOffset="24:33" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.39.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="diuretics" preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="62:72" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.39.e.1" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="the carvedilol dose" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.39.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.39.e.1"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.41" text="Such episodes do not preclude subsequent successful titration of, or a favorable response to, carvedilol. " type="negative"><entity charOffset="94:104" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.41.e.0" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="carvedilol." preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="71:80" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.41.e.1" text="favorable" type="Biomedical_Entity"><Normalization><mmtx cui="C0309049" phraseText="a favorable response to," preferredWord="FAVOR" semType="phsu, orch, vita"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.41.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.41.e.0"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.47" text="COREG may be used with caution, however, in patients who do not respond to, or cannot tolerate, other antihypertensive agents. " type="negative"><entity charOffset="0:5" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.47.e.0" text="coreg" type="Biomedical_Entity"><Normalization><mmtx cui="C0719509" phraseText="COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><entity charOffset="102:125" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.47.e.1" text="antihypertensive agents" type="Biomedical_Entity"><Normalization><mmtx cui="C0003364" phraseText="other antihypertensive agents." preferredWord="Antihypertensive Agents" semType="phsu"/><RxNorm RxCui="968"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.47.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.47.e.1"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.48" text="It is prudent, if COREG is used, to use the smallest effective dose, so that inhibition of endogenous or exogenous  -agonists is minimized." type="negative"><entity charOffset="117:125" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.48.e.0" text="agonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0243192" phraseText="exogenous  -agonists" preferredWord="agonists" semType="phsu"/><RxNorm RxCui="608609"/></Normalization></entity><entity charOffset="18:23" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.48.e.1" text="coreg" type="Biomedical_Entity"><Normalization><mmtx cui="C0719509" phraseText="COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.48.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.48.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55" lineNumber="49" text="Patients subject to spontaneous hypoglycemia, or diabetic patients receiving insulin or oral hypoglycemic agents, should be cautioned about these possibilities." type="irregular"><entity charOffset="49:66" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.0" text="diabetic patients" type="SPAN"/><entity charOffset="77:84" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.1" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="88:112" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.2" text="oral hypoglycemic agents" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemic agents," preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="114:133" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.3" text="should be cautioned" type="Caution_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.3"><relations><relation type="hasContext"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.2"/></relation><relation type="hasObject"><labelDrug text="COREG"/><normalization><mmtx><preferredWord>Coreg</preferredWord><phraseText>discontinuing COREG</phraseText><cuiCode>C0719509</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.55.e.2"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.56" text="In heart failure patients with diabetes, carvedilol therapy may lead to worsening hyperglycemia, which responds to intensification of hypoglycemic therapy. " type="negative"><entity charOffset="41:51" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.56.e.0" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="carvedilol therapy" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="134:146" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.56.e.1" text="hypoglycemic" type="Biomedical_Entity"><Normalization><mmtx cui="C0020616" phraseText="responds to intensification of hypoglycemic therapy." preferredWord="Hypoglycemic Agents" semType="phsu"/><RxNorm RxCui="5604"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.56.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.56.e.1"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.57" text="It is recommended that blood glucose be monitored when carvedilol dosing is initiated, adjusted, or discontinued. " type="negative"><entity charOffset="55:65" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.57.e.0" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="carvedilol dosing" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="29:36" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.57.e.1" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="that blood glucose" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.57.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.57.e.0"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86" text="Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients treated with alpha-1 blockers (COREG is an alpha/beta blocker). " type="negative"><entity charOffset="115:131" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86.e.0" text="alpha blockers" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="treated with alpha-1 blockers" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="145:163" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86.e.1" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="an alpha/beta blocker" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="133:138" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86.e.2" text="coreg" type="Biomedical_Entity"><Normalization><mmtx cui="C0719509" phraseText="(COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86.e.2"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86.e.2" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.86.e.1"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.89" text="There does not appear to be a benefit of stopping alpha-1 blocker therapy prior to cataract surgery." type="negative"><entity charOffset="41:49" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.89.e.0" text="stopping" type="Biomedical_Entity"><Normalization><mmtx cui="C0723457" phraseText="a benefit of stopping alpha-1 blocker therapy" preferredWord="Stop brand of fluoride" semType="inch, phsu"/><RxNorm RxCui="220037"/></Normalization></entity><entity charOffset="50:65" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.89.e.1" text="alpha blocker" type="Biomedical_Entity"><Normalization><mmtx cui="C0001641" phraseText="a benefit of stopping alpha-1 blocker therapy" preferredWord="Adrenergic alpha-Antagonists" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.89.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.89.e.1"/></sentence><sentence biomedicalEntities="6" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92" lineNumber="91" text="Interactions of carvedilol with potent inhibitors of CYP2D6 isoenzyme (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol [see Clinical Pharmacology (12.3)]. " type="regular"><anaphoraRelation><anaphoraEntity charOffset="158:169" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.9" text="these drugs" type="Expression"/><antecedentEntity charOffset="32-69" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.0" text="potent inhibitors of CYP2D6 isoenzyme" type="Drug_Class"/></anaphoraRelation><entity charOffset="32:69" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.0" text="potent inhibitors of CYP2D6 isoenzyme" type="Drug_Class"><Normalization><mmtx cui="C1442929" phraseText="of CYP2D6 isoenzyme" preferredWord="Clinically relevant isoenzyme" semType="phsu, aapp, enzy"/><RxNorm RxCui="402226"/></Normalization></entity><entity charOffset="79:88" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.1" text="quinidine" type="Drug"><Normalization><mmtx cui="C0034414" phraseText="such as quinidine," preferredWord="Quinidine" semType="phsu, orch"/><RxNorm RxCui="9068"/></Normalization></entity><entity charOffset="90:100" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.2" text="fluoxetine" type="Drug"><Normalization><mmtx cui="C0016365" phraseText="fluoxetine," preferredWord="Fluoxetine" semType="phsu, orch"/><RxNorm RxCui="227224"/></Normalization></entity><entity charOffset="102:112" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.3" text="paroxetine" type="Drug"><Normalization><mmtx cui="C0070122" phraseText="paroxetine," preferredWord="Paroxetine" semType="phsu, orch"/><RxNorm RxCui="32937"/></Normalization></entity><entity charOffset="118:129" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.4" text="propafenone" type="Drug"><Normalization><mmtx cui="C0033429" phraseText="propafenone" preferredWord="Propafenone" semType="phsu, orch"/><RxNorm RxCui="8754"/></Normalization></entity><entity charOffset="191:212" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.11" text="increase blood levels" type="Increase_Interaction"/><entity charOffset="239:249" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.13" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="blood levels of the R(+) enantiomer of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><mmtx cui="C0054836" phraseText="blood levels of the R(+) enantiomer of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.1" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.0"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.2" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.0"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.3" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.0"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.4" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.0"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.11"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.13"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.9"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.9" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.13" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.92.e.11" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95" lineNumber="95" text="Patients taking both agents with  -blocking properties and a drug that can deplete catecholamines (e.g., reserpine and monoamine oxidase inhibitors) should be observed closely for signs of hypotension and/or severe bradycardia." type="regular"><entity charOffset="21:54" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.0" text="agents with β-blocking properties" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="both agents with  -blocking properties" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="61:97" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.1" text="drug that can deplete catecholamines" type="Drug_Class"><Normalization><mmtx cui="C0013227" phraseText="a drug" preferredWord="Pharmaceutical Preparations" semType="phsu"/><mmtx cui="C1254351" phraseText="a drug" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0007412" phraseText="catecholamines" preferredWord="Catecholamines" semType="phsu, nsba"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="105:114" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.2" text="reserpine" type="Drug"><Normalization><mmtx cui="C0035179" phraseText="reserpine" preferredWord="Reserpine" semType="phsu, orch"/><RxNorm RxCui="9260"/></Normalization></entity><entity charOffset="119:147" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.3" text="monoamine oxidase inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0026457" phraseText="monoamine oxidase inhibitors" preferredWord="Monoamine Oxidase Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1565"/></Normalization></entity><entity charOffset="189:200" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.6" text="hypotension" type="Specific_Interaction"/><entity charOffset="215:226" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.8" text="bradycardia" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.2" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.1"/><classClassMembership drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.3"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.6"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.ddi.2"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.8"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.1" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.95.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96" lineNumber="97" text="Concomitant administration of clonidine with agents with  -blocking properties may potentiate blood-pressure- and heart-rate-lowering effects. " type="regular"><entity charOffset="30:39" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.0" text="clonidine" type="Drug"><Normalization><mmtx cui="C0009014" phraseText="Concomitant administration of clonidine" preferredWord="Clonidine" semType="phsu, orch"/><RxNorm RxCui="2599"/></Normalization></entity><entity charOffset="45:78" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.1" text="agents with β-blocking properties" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="83:109|125:141" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.2" text="potentiate blood-pressure- lowering effects" type="Specific_Interaction"/><entity charOffset="83:93|114:141" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.4" text="potentiate heart-rate-lowering effects" type="Specific_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.2"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.ddi.2"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.4"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.1" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.96.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100" lineNumber="101" text="Modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21 renal transplant subjects suffering from chronic vascular rejection. " type="regular"><entity charOffset="7:31|45:59" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.0" text="increases in mean trough concentrations" type="Increase_Interaction"/><entity charOffset="32:44" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="Modest increases in mean trough cyclosporine concentrations" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="98:108" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.3" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="initiation of carvedilol treatment" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="122:124" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.4" text="21" type="SPAN"/><entity charOffset="125:192" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.5" text="renal transplant subjects suffering from chronic vascular rejection" type="SPAN"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.0"><relations><relation type="hasEvidence"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.5" ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.2" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.3" evidence="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.4" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101" lineNumber="101" text="In about 30% of subjects, the dose of cyclosporine had to be reduced in order to maintain cyclosporine concentrations within the therapeutic range, while in the remainder no adjustment was needed. " type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100" Text="Modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21 renal transplant subjects suffering from chronic vascular rejection. "/><anaphoraEntity charOffset="16:24" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.e.3" text="subjects" type="Expression"/><antecedentEntity charOffset="125:192" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.5" text="renal transplant subjects suffering from chronic vascular rejection" type="SPAN"/></anaphoraRelation><entity charOffset="30:34|51:68" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.e.0" text="dose had to be reduced" type="Caution_Interaction"/><entity charOffset="38:50" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="the dose of cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="16:24" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.e.5" text="subjects" type="SPAN"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.e.0"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100" text="Modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21 renal transplant subjects suffering from chronic vascular rejection. "><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.100.e.3"/></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.101.e.5"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103" lineNumber="101" text="Due to wide interindividual variability in the dose adjustment required, it is recommended that cyclosporine concentrations be monitored closely after initiation of carvedilol therapy and that the dose of cyclosporine be adjusted as appropriate." type="regular"><entity charOffset="96:108" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.0" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="that cyclosporine concentrations" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="165:175" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.1" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="initiation of carvedilol therapy" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="127:136" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.2" text="monitored" type="Caution_Interaction"/><entity charOffset="197:201|218:229" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.4" text="dose be adjusted" type="Caution_Interaction"/><entity charOffset="205:217" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.6" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="the dose of cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.2"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.0"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.ddi.2"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.1" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.2" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.6" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.103.e.4" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107" lineNumber="105" text="Digoxin concentrations are increased by about 15% when digoxin and carvedilol are administered concomitantly. " type="regular"><entity charOffset="8:36" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.0" text="concentrations are increased" type="Increase_Interaction"/><entity charOffset="0:7" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.2" text="Digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="Digoxin concentrations" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="67:77" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.3" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.2" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.3" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.107.e.0" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108" lineNumber="105" text="Therefore, increased monitoring of digoxin is recommended when initiating, adjusting, or discontinuing COREG [see Clinical Pharmacology (12.5)]." type="regular"><entity charOffset="21:31" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.0" text="monitoring" type="Caution_Interaction"/><entity charOffset="35:42" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.2" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="increased monitoring of digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="103:108" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.3" text="COREG" type="Drug"><Normalization><mmtx cui="C0719509" phraseText="discontinuing COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.0"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.2" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.3" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.108.e.0" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110" lineNumber="109" text="Rifampin reduced plasma concentrations of carvedilol by about 70% [see Clinical Pharmacology (12.5)]. " type="regular"><entity charOffset="0:8" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.0" text="Rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="Rifampin reduced plasma concentrations of carvedilol" preferredWord="Rifampin" semType="orch, antb"/><mmtx cui="C0035608" phraseText="Rifampin reduced plasma concentrations of carvedilol" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="42:52" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.1" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="Rifampin reduced plasma concentrations of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><mmtx cui="C0054836" phraseText="Rifampin reduced plasma concentrations of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="9:38" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.2" text="reduced plasma concentrations" type="Decrease_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.1" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.2" type="Decrease_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.111" lineNumber="109" text="Cimetidine increased AUC by about 30% but caused no change in Cmax[see Clinical Pharmacology (12.5)]." type="irregular"><entity charOffset="0:10" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.111.e.0" text="Cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="Cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="11:24" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.111.e.1" text="increased AUC" type="Increase_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.111.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.111.e.1"><relations><relation type="hasObject"><ellipsisSentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110" text="Rifampin reduced plasma concentrations of carvedilol by about 70% [see Clinical Pharmacology (12.5)]. "><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.110.e.1"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.111.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.111.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113" lineNumber="113" text="Amiodarone, and its metabolite desethyl amiodarone, inhibitors of CYP2C9 and P-glycoprotein, increased concentrations of the S(-)-enantiomer of carvedilol by at least 2-fold [see Clinical Pharmacology (12.5)]. " type="regular"><entity charOffset="52:91" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.0" text="inhibitors of CYP2C9 and P-glycoprotein" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.1" text="Amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="Amiodarone," preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="20:50" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.2" text="metabolite desethyl amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="its metabolite desethyl amiodarone," preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="131045"/></Normalization></entity><entity charOffset="93:117" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.5" text="increased concentrations" type="Increase_Interaction"/><entity charOffset="144:154" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.7" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="enantiomer of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.2" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.0"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.1" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.0"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.5"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.7" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.5" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.2" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.7" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.5" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.113.e.2"/></sentence><sentence biomedicalEntities="4" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114" lineNumber="113" text="The concomitant administration of amiodarone or other CYP2C9 inhibitors such as fluconazole with COREG may enhance the  -blocking properties of carvedilol resulting in further slowing of the heart rate or cardiac conduction. " type="regular"><entity charOffset="34:44" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.0" text="amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="The concomitant administration of amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="54:71" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.1" text="CYP2C9 inhibitors" type="Drug_Class"><Normalization><RxNorm RxCui="687278"/></Normalization></entity><entity charOffset="80:91" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.2" text="fluconazole" type="Drug"><Normalization><mmtx cui="C0016277" phraseText="other CYP2C9 inhibitors such as fluconazole" preferredWord="Fluconazole" semType="phsu, orch"/><RxNorm RxCui="4450"/></Normalization></entity><entity charOffset="144:154" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.5" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="the  -blocking properties of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="176:186|191:201" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.6" text="slowing of heart rate" type="Specific_Interaction"/><entity charOffset="176:186|205:223" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.8" text="slowing of cardiac conduction" type="Specific_Interaction"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.0" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.1"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.2" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.1"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.6"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.5"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.ddi.2"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.5"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.5" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.6" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="0" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115" lineNumber="113" text="Patients should be observed for signs of bradycardia or heart block, particularly when one agent is added to pre-existing treatment with the other." type="irregular"><anaphoraRelation><antecedentSentence ID="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114" Text="The concomitant administration of amiodarone or other CYP2C9 inhibitors such as fluconazole with COREG may enhance the  -blocking properties of carvedilol resulting in further slowing of the heart rate or cardiac conduction. "/><anaphoraEntity charOffset="87:96" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.4" text="one agent" type="Expression"/><antecedentEntity charOffset="54:71" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.1" text="CYP2C9 inhibitors" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><antecedentSentence ID="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114" Text="The concomitant administration of amiodarone or other CYP2C9 inhibitors such as fluconazole with COREG may enhance the  -blocking properties of carvedilol resulting in further slowing of the heart rate or cardiac conduction. "/><anaphoraEntity charOffset="141:146" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.6" text="other" type="Expression"/><antecedentEntity charOffset="144:154" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.114.e.5" text="carvedilol" type="Drug"/></anaphoraRelation><entity charOffset="41:52" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.0" text="bradycardia" type="Specific_Interaction"/><entity charOffset="56:67" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.2" text="heart block" type="Specific_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.0"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.ddi.2"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.2"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.6"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.4" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.6" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.115.e.0" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117" lineNumber="117" text="Conduction disturbance (rarely with hemodynamic compromise) has been observed when COREG is co-administered with diltiazem. " type="regular"><entity charOffset="83:88" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.0" text="COREG" type="Drug"><Normalization><mmtx cui="C0719509" phraseText="COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><entity charOffset="113:122" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.1" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="co-administered with diltiazem." preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="0:59" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.2" text="Conduction disturbance (rarely with hemodynamic compromise)" type="Specific_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.1" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.117.e.2" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="5" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118" lineNumber="117" text="As with other agents with  -blocking properties, if COREG is to be administered with calcium channel blockers of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored." type="regular"><entity charOffset="14:47" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.0" text="agents with β-blocking properties" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="As with other agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="52:57" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.1" text="COREG" type="Drug"><Normalization><mmtx cui="C0719509" phraseText="COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><entity charOffset="85:109" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.3" text="calcium channel blockers" type="Drug_Class"><Normalization><mmtx cui="C0006684" phraseText="administered with calcium channel blockers of the verapamil" preferredWord="Calcium Channel Blockers" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="117:126" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.4" text="verapamil" type="Drug"><Normalization><mmtx cui="C0042523" phraseText="administered with calcium channel blockers of the verapamil" preferredWord="Verapamil" semType="phsu, orch"/><RxNorm RxCui="11170"/></Normalization></entity><entity charOffset="130:139" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.5" text="diltiazem" type="Drug"><Normalization><mmtx cui="C0012373" phraseText="diltiazem type," preferredWord="Diltiazem" semType="phsu, orch"/><RxNorm RxCui="203211"/></Normalization></entity><entity charOffset="195:204" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.8" text="monitored" type="Caution_Interaction"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.1" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.0"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.4" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.3"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.5" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.3"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.8"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.3" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.118.e.8" type="Caution_Interaction"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.119" text="7.8 Insulin or Oral Hypoglycemics" type="negative"><entity charOffset="4:11" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.119.e.0" text="insulin" type="Biomedical_Entity"><Normalization><mmtx cui="C1579433" phraseText="7.8 Insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="15:33" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.119.e.1" text="oral hypoglycemics" type="Biomedical_Entity"><Normalization><mmtx cui="C0359086" phraseText="Oral Hypoglycemics" preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.119.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.119.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120" lineNumber="121" text="Agents with  -blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics. " type="regular"><entity charOffset="0:33" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.0" text="Agents with β-blocking properties" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="Agents with  -blocking properties" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="81:88" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.1" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="the blood-sugar-reducing effect of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="the blood-sugar-reducing effect of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="the blood-sugar-reducing effect of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><mmtx cui="C0021641" phraseText="the blood-sugar-reducing effect of insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="the blood-sugar-reducing effect of insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="the blood-sugar-reducing effect of insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="93:111" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.2" text="oral hypoglycemics" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemics." preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="50:77" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.3" text="blood-sugar-reducing effect" type="Specific_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.3"><relations><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.1"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.2"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.1" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.3" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.2" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.3" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121" lineNumber="121" text="Therefore, in patients taking insulin or oral hypoglycemics, regular monitoring of blood glucose is recommended [see Warnings and Precautions (5.6)]." type="irregular"><entity charOffset="30:37" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.0" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="41:59" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.1" text="oral hypoglycemics" type="Drug_Class"><Normalization><mmtx cui="C0359086" phraseText="oral hypoglycemics," preferredWord="Oral hypoglycemic" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="69:79" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.2" text="monitoring" type="Caution_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.2"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.1"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120" text="Agents with  -blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics. "><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.120.e.0"/></ellipsisSentence></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.1"/><pair ddi="true" e1="labelDrug" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.121.e.0"/></sentence><sentence biomedicalEntities="5" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123" lineNumber="125" text="If treatment with COREG is to be continued perioperatively, particular care should be taken when anesthetic agents which depress myocardial function, such as ether, cyclopropane, and trichloroethylene, are used [see Overdosage (10)]." type="regular"><entity charOffset="18:23" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.0" text="COREG" type="Drug"><Normalization><mmtx cui="C0719509" phraseText="treatment with COREG" preferredWord="Coreg" semType="phsu, orch"/><RxNorm RxCui="216221"/></Normalization></entity><entity charOffset="97:148" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.1" text="anesthetic agents which depress myocardial function" type="Drug_Class"><Normalization><mmtx cui="C0002932" phraseText="anesthetic agents" preferredWord="Anesthetics" semType="phsu"/><RxNorm RxCui="817"/></Normalization></entity><entity charOffset="158:163" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.2" text="ether" type="Drug"><Normalization><mmtx cui="C0014994" phraseText="such as ether," preferredWord="ethyl ether" semType="phsu, orch"/><mmtx cui="C0014996" phraseText="such as ether," preferredWord="Ethers" semType="phsu, orch"/><mmtx cui="C1161324" phraseText="such as ether," preferredWord="Etherum, ether, Homeopathic preparation" semType="phsu, orch"/><RxNorm RxCui="1363043"/></Normalization></entity><entity charOffset="165:177" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.3" text="cyclopropane" type="Drug"><Normalization><mmtx cui="C0010587" phraseText="cyclopropane," preferredWord="cyclopropane" semType="phsu, orch"/><RxNorm RxCui="3004"/></Normalization></entity><entity charOffset="183:200" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.4" text="trichloroethylene" type="Drug"><Normalization><mmtx cui="C0040905" phraseText="trichloroethylene," preferredWord="Trichloroethylene" semType="phsu, orch"/><RxNorm RxCui="10777"/></Normalization></entity><entity charOffset="71:91" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.5" text="care should be taken" type="Caution_Interaction"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.2" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.1"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.3" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.1"/><drugClassMembership drug="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.4" drugClass="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.1"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.5"><relations><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.0"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.1" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.123.e.5" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126" lineNumber="131" text="In a pharmacokinetic trial conducted in 106 Japanese subjects with heart failure, coadministration of small loading and maintenance doses of amiodarone with carvedilol resulted in at least a 2-fold increase in the steady-state trough concentrations of S(-)-carvedilol [see Drug Interactions (7.6)]." type="regular"><entity charOffset="40:61" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.0" text="106 Japanese subjects" type="SPAN"/><entity charOffset="67:80" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.1" text="heart failure" type="SPAN"><Normalization><mmtx cui="C0018801" phraseText="with heart failure," preferredWord="Heart failure" semType="dsyn"/><mmtx cui="C0018802" phraseText="with heart failure," preferredWord="Congestive heart failure" semType="dsyn"/></Normalization></entity><entity charOffset="141:151" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.2" text="amiodarone" type="Drug"><Normalization><mmtx cui="C0002598" phraseText="maintenance doses of amiodarone" preferredWord="Amiodarone" semType="phsu, orch"/><RxNorm RxCui="203114"/></Normalization></entity><entity charOffset="257:267" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.3" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="198:248" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.4" text="increase in the steady-state trough concentrations" type="Increase_Interaction"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.4"><relations><relation type="hasContext"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.1"/></relation><relation type="hasEvidence"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.0"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.2"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.1" ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.2" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.3" evidence="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.0" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.126.e.4" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128" lineNumber="135" text="In a pharmacokinetic trial conducted in 10 healthy male subjects, cimetidine (1,000 mg/day) increased the steady-state AUC of carvedilol by 30% with no change in Cmax [see Drug Interactions (7.5)]." type="regular"><entity charOffset="40:64" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.0" text="10 healthy male subjects" type="SPAN"/><entity charOffset="66:76" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.1" text="cimetidine" type="Drug"><Normalization><mmtx cui="C0008783" phraseText="cimetidine" preferredWord="Cimetidine" semType="phsu, orch"/><RxNorm RxCui="2541"/></Normalization></entity><entity charOffset="92:122" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.2" text="increased the steady-state AUC" type="Increase_Interaction"/><entity charOffset="126:136" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.4" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="the steady-state AUC of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.2"><relations><relation type="hasEvidence"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.4" evidence="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.0" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.128.e.2" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130" lineNumber="139" text="Following concomitant administration of carvedilol (25 mg once daily) and digoxin (0.25 mg once daily) for 14 days, steady-state AUC and trough concentrations of digoxin were increased by 14% and 16%, respectively, in 12 hypertensive subjects [see Drug Interactions (7.4)]." type="regular"><entity charOffset="116:132|144:158|170:184" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.0" text="steady-state AUC concentrations were increased" type="Increase_Interaction"/><entity charOffset="137:158|170:184" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.2" text="trough concentrations were increased" type="Increase_Interaction"/><entity charOffset="162:169" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.4" text="digoxin" type="Drug"><Normalization><mmtx cui="C0012265" phraseText="trough concentrations of digoxin" preferredWord="Digoxin" semType="strd, phsu, carb"/><RxNorm RxCui="3407"/></Normalization></entity><entity charOffset="40:50" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.5" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="concomitant administration of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="218:220" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.6" text="12" type="SPAN"/><entity charOffset="221:242" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.7" text="hypertensive subjects" type="SPAN"/><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.0"><relations><relation type="hasContext"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.5"/></relation><relation type="hasEvidence"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.ddi.2"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.2"><relations><relation type="hasContext"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.5"/></relation><relation type="hasEvidence"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.6"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.4"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.7" ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.5" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.4" evidence="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.6" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.130.e.0" type="Increase_Interaction"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.132" text="In 12 healthy subjects, combined administration of carvedilol (25 mg once daily) and a single dose of glyburide did not result in a clinically relevant pharmacokinetic interaction for either compound." type="negative"><entity charOffset="102:111" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.132.e.0" text="glyburide" type="Biomedical_Entity"><Normalization><mmtx cui="C0017628" phraseText="a single dose of glyburide" preferredWord="Glyburide" semType="phsu, orch"/><RxNorm RxCui="4815"/></Normalization></entity><entity charOffset="51:61" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.132.e.1" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="combined administration of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.132.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.132.e.0"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.134" text="A single oral dose of carvedilol 25 mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg in 12 subjects with hypertension. " type="negative"><entity charOffset="22:38" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.134.e.0" text="carvedilol 25 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0984555" phraseText="A single oral dose of carvedilol 25 mg" preferredWord="carvedilol 25 MG" semType="clnd"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="99:124" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.134.e.1" text="hydrochlorothiazide 25 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0986526" phraseText="the pharmacokinetics of a single oral dose of hydrochlorothiazide 25 mg" preferredWord="Hydrochlorothiazide 25 MG" semType="clnd"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.134.e.0" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.134.e.1"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.135" text="Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol." type="negative"><entity charOffset="71:81" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.135.e.0" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="no effect on the pharmacokinetics of carvedilol." preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="10:29" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.135.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.135.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.135.e.0"/></sentence><sentence biomedicalEntities="2" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137" lineNumber="151" text="In a pharmacokinetic trial conducted in 8 healthy male subjects, rifampin (600 mg daily for 12 days) decreased the AUC and Cmax of carvedilol by about 70% [see Drug Interactions (7.5)]." type="regular"><entity charOffset="40:63" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.0" text="8 healthy male subjects" type="SPAN"/><entity charOffset="65:73" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.1" text="rifampin" type="Drug"><Normalization><mmtx cui="C0035608" phraseText="rifampin" preferredWord="Rifampin" semType="orch, antb"/><RxNorm RxCui="9384"/></Normalization></entity><entity charOffset="101:118" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.2" text="decreased the AUC" type="Decrease_Interaction"/><entity charOffset="101:114|123:127" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.4" text="decreased the Cmax" type="Decrease_Interaction"/><entity charOffset="131:141" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.6" text="carvedilol" type="Drug"><Normalization><mmtx cui="C0054836" phraseText="Cmax of carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.ddi.1"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.2"><relations><relation type="hasEvidence"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.ddi.2"><interaction trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.4"><relations><relation type="hasEvidence"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.0"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.1"/></relation><relation type="hasObject"><entity id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.6" evidence="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.0" trigger="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.137.e.2" type="Decrease_Interaction"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.139" text="In a trial of 12 healthy subjects, combined oral administration of carvedilol 25 mg once daily and torsemide 5 mg once daily for 5 days did not result in any significant differences in their pharmacokinetics compared with administration of the drugs alone." type="negative"><entity charOffset="99:113" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.139.e.0" text="torsemide 5 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0990872" phraseText="torsemide 5 mg" preferredWord="torsemide 5 MG" semType="clnd"/><RxNorm RxCui="38413"/></Normalization></entity><entity charOffset="67:83" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.139.e.1" text="carvedilol 25 mg" type="Biomedical_Entity"><Normalization><mmtx cui="C0984555" phraseText="oral administration of carvedilol 25 mg" preferredWord="carvedilol 25 MG" semType="clnd"/><RxNorm RxCui="20352"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.139.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.139.e.0"/></sentence><sentence id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141" text="Carvedilol (12.5 mg twice daily) did not have an effect on the steady-state prothrombin time ratios and did not alter the pharmacokinetics of R(+)- and S(-)-warfarin following concomitant administration with warfarin in 9 healthy volunteers." type="negative"><entity charOffset="208:216" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.0" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="concomitant administration with warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="0:10" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.1" text="carvedilol" type="Biomedical_Entity"><Normalization><mmtx cui="C0054836" phraseText="Carvedilol" preferredWord="carvedilol" semType="phsu, orch"/><RxNorm RxCui="20352"/></Normalization></entity><entity charOffset="157:165" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.2" text="warfarin" type="Biomedical_Entity"><Normalization><mmtx cui="C0043031" phraseText="warfarin" preferredWord="Warfarin" semType="phsu, orch, hops"/><RxNorm RxCui="11289"/></Normalization></entity><entity charOffset="76:87" id="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.3" text="prothrombin" type="Biomedical_Entity"><Normalization><mmtx cui="C0033706" phraseText="an effect on the steady-state prothrombin time ratios" preferredWord="Prothrombin" semType="bacs, phsu, aapp"/><RxNorm RxCui="1441688"/></Normalization></entity><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.0"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.3" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.0"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.2"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.1" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.3"/><pair ddi="false" e1="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.3" e2="Dailymed.c57982f2-c7da-488a-7ea9-b9609439ac68.s.141.e.2"/></sentence><positiveExamples number="27"/><negativeExamples number="30"/></document>